General
Preferred name
LEVONORDEFRIN
Synonyms
α-methylnoradrenaline ()
corbadrine ()
(-)-Cobefrin ()
(-)-α-Methylnoradrenaline ()
(-)-Nordefrin ()
(-)-¦Á-Methylnoradrenaline ()
BA-2818 ()
L-nordefrin ()
L-norephedrine, 3,4-dihydroxy- ()
Corbadrina ()
BA 2818 ()
Nordefrin (-)-form ()
NSC-757084 ()
Nordefrin, l- ()
L-.alpha.-methylnoradrenaline ()
Neo-cobefrin ()
P&D ID
PD001917
CAS
829-74-3
18829-78-2
Tags
drug
available
Approved by
FDA
First approval
1960
Drug indication
Discovery agent
Drug Status
approved
Max Phase
4.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION α-methylnoradrenaline (corbadrine) is a catecholamine sympathomimetic drug. (GtoPdb)
DESCRIPTION Levonordefrin, a common alternative to levoepinephrine as a vasoconstrictor in dental local agent that can suppress or relieve pain, is usually used in fivefold higher concentrations. Levonordefrin is generally considered equivalent to epinephrine[1].
Compound Sets
16
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
Guide to Pharmacology
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
Prestwick Chemical Library
ReFrame library
The Spectrum Collection
External IDs
38
Properties
(calculated by RDKit )
Molecular Weight
183.09
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
4
Rotatable Bonds
2
Ring Count
1
Aromatic Ring Count
1
cLogP
0.48
TPSA
86.71
Fraction CSP3
0.33
Chiral centers
2.0
Largest ring
6.0
QED
0.5
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, SLC6A2
Adrenergic Receptor
Indication
hemorrhage
MOA
Vasodilator
Pathway
GPCR/G protein
Neuronal Signaling
Source data